Articles

Export 82 results:
Filters: Keyword is Type 1 diabetes  [Clear All Filters]
2012
Chatenoud L, Waldmann H.  2012.  CD3 Monoclonal Antibodies: A First Step Towards Operational Immune Tolerance in the Clinic. The Review of Diabetic Studies. 9(4):372-381.PDF icon PDF (143.4 KB)
Coppieters KT, Hansen BSehested, von Herrath MG.  2012.  Clinical Potential of Antigen-Specific Therapies in Type 1 Diabetes. The Review of Diabetic Studies. 9(4):328-337.PDF icon PDF (560.75 KB)
Driver JP, Chen Y-G, Mathews CE.  2012.  Comparative Genetics: Synergizing Human and NOD Mouse Studies for Identifying Genetic Causation of Type 1 Diabetes. The Review of Diabetic Studies. 9(4):169-187.PDF icon PDF (345.36 KB)
Baxter AG, Jordan MA.  2012.  From Markers to Molecular Mechanisms: Type 1 Diabetes in the Post-GWAS Era. The Review of Diabetic Studies. 9(4):201-223.PDF icon PDF (1.02 MB)
Holmes N, Cooke A.  2012.  Genetic Analysis of Type 1 Diabetes: Embryonic Stem Cells as New Tools to Unlock Biological Mechanisms in Type 1 Diabetes. The Review of Diabetic Studies. 9(4):137-147.PDF icon PDF (170.47 KB)
Zaccone P, Hall SW.  2012.  Helminth Infection and Type 1 Diabetes. The Review of Diabetic Studies. 9(4):272-286.PDF icon PDF (851.53 KB)
Weigmann B, Franke RKristina, Daniel C.  2012.  Immunotherapy in Autoimmune Type 1 Diabetes. The Review of Diabetic Studies. 9(2-3):68-81.PDF icon PDF (186.38 KB)
Di Caro V, Giannoukakis N, Trucco M.  2012.  In vivo Delivery of Nucleic Acid-Formulated Microparticles as a Potential Tolerogenic Vaccine for Type 1 Diabetes. The Review of Diabetic Studies. 9(4):348-356.PDF icon PDF (5.11 MB)
Mandrup-Poulsen T.  2012.  Interleukin-1 Antagonists and Other Cytokine Blockade Strategies for Type 1 Diabetes. The Review of Diabetic Studies. 9(4):338-347.PDF icon PDF (204.6 KB)
Jin Y, She J-X.  2012.  Novel Biomarkers in Type 1 Diabetes. The Review of Diabetic Studies. 9(4):224-235.PDF icon PDF (159.23 KB)
Graham KL, Sutherland RM, Mannering SI, Zhao Y, Chee J, Krishnamurthy B, Thomas HE, Lew AM, Kay TWH.  2012.  Pathogenic Mechanisms in Type 1 Diabetes: The Islet is Both Target and Driver of Disease. The Review of Diabetic Studies. 9(4):148-168.PDF icon PDF (7.18 MB)
Cerosaletti K, Buckner JH.  2012.  Protein Tyrosine Phosphatases and Type 1 Diabetes: Genetic and Functional Implications of PTPN2 and PTPN22. The Review of Diabetic Studies. 9(4):188-200.PDF icon PDF (763.08 KB)
Petzold C, Schallenberg S, Stern JNH, Kretschmer K.  2012.  Targeted Antigen Delivery to DEC-205+ Dendritic Cells for Tolerogenic Vaccination. The Review of Diabetic Studies. 9(4):305-318.PDF icon PDF (379 KB)
Prasad S, Xu D, Miller SD.  2012.  Tolerance Strategies Employing Antigen-Coupled Apoptotic Cells and Carboxylated PLG Nanoparticles for the Treatment of Type 1 Diabetes. The Review of Diabetic Studies. 9(4):319-327.PDF icon PDF (530.29 KB)
F Wong S, Wen L.  2012.  Type 1 Diabetes Therapy Beyond T Cell Targeting: Monocytes, B Cells, and Innate Lymphocytes. The Review of Diabetic Studies. 9(4):289-304.PDF icon PDF (823.03 KB)
Nurminen N, Oikarinen S, Hyöty H.  2012.  Virus Infections as Potential Targets of Preventive Treatments for Type 1 Diabetes. The Review of Diabetic Studies. 9(4):260-271.PDF icon PDF (416.12 KB)
2011
Regnell SE, Lernmark Å.  2011.  Hepatic Steatosis in Type 1 Diabetes. The Review of Diabetic Studies. 8(4):454-467.PDF icon PDF (228.99 KB)

Pages